What’s
happening in basic CF research?
J. Wine, Sheraton Hotel, Palo Alto, August 9, 1998
This early talk outlined some of
the general strategies for maintaining lung function by preventing or
minimizing airway infections.
Its main ideas remain valid a decade later (JJW/7/4/2008)
This talk has four parts.
Current understanding
of
CF
Overview of CF.
-
CF stands for cystic fibrosis.
-
CF affects our vast internal plumbing system
-
The biological pipes in our bodies are lined with special cells.
-
These cells keep the inner surfaces of pipes clean and free-flowing.
-
This huge inner surface consists of wet epithelia (a special
kind
of skin).
-
CF affects the wet epithelia lining our inner organs.
-
CF disrupts the processes that keep our plumbing clean and free-flowing.
-
CF affects the:
pancreas, liver, gallbladder, intestines,
salivary and sweat glands, reproductive tract, sinuses, and lungs.
Cystic fibrosis is a single gene disease.
-
1/4 of the children in CF families will have CF.
-
The responsible gene has been identified.
-
Genes are named for the diseases they cause when they are broken.
-
It is difficult to determine what a gene really does.
Current understanding of CF: from gene to syndrome.
-
CF arises from one gene, one protein, one basic defect.
-
The basic defect is loss of anion conductance.
-
The loss occurs across epithelial apical membranes.
Anion = negative ions (chloride, bicarbonate, glutathione)
Conductance = ability to pass through
Epithelia = skin cells (internal, wet skin)
Apical membrane = the cell part facing inside the pipe.
-
The CF gene makes a protein called CFTR.
Current understanding of CF: from gene to syndrome.
-
CFTR is an anion channel (a tiny valve that lets (-) ions cross the
membrane.
-
CFTR is important for secreting water
-
CFTR is important for absorbing salt
-
In CF, secretions may lack water, or have more salt, or both
-
Other important anions, such as bicarbonate and glutathione, are not
secreted.
Current understanding of CF: from gene to syndrome.
-
Hyposecretion of fluid leads to blocked ducts and airways
-
Hyposecretion of HCO3- alters pH.
-
Hyposecretion of glutathione increases oxidative stress
-
Hypoabsorbtion of salt compromises mucosal defenses
-
Hypoabsorbtion of salt leads to salt wasting (sweat)
Current understanding of CF: from gene to syndrome.
-
Blocked exocrine ducts prevent the secretion of critical enzymes
-
The paradigm for this is loss of pancreatic enzymes
-
By analogy, antibiotics from lung submucosal glands may be trapped.
-
Larger ducts can be blocked, such as the sperm duct.
-
Even large structures like intestines can be blocked.
Current understanding of CF: from gene to syndrome.
-
Blocked ducts can lead to destruction of the blocked organ.
-
Blocked intestines are lethal.
-
Loss of exocrine secretions has widespread consequences.
Evidence favoring current
understanding
of CF
CFTR is an anion channel.
-
It conducts Cl- > HCO3- >>
large, univalent
anions >> polyvalent anions.
-
Mutations that reduce anion conductance through CFTR cause CF.
-
The severity of CF correlates with the degree of anion conductance loss.
-
Other anion channels can partially substitute for CFTR.
-
Organs with anion channels in parallel with CFTR are less affected.
-
People with other anion channels are less affected.
-
Animals with other anion channels are less affected.
Approaches to treating CF
Gene therapy for CF.
-
16 gene therapy trials underway or completed.
-
No clear successes yet.
-
Airways have been found to be highly resistant to transfection
-
Strategies for circumventing this resistance are being pursued
-
The only phase III trial for CF is now nearing completion at Stanford.
-
This trial used AAV and the sinus model; it is still blinded.
-
Most new gene therapy trials are aimed at cancer.
-
A company called Kimerigen has proposed a novel approach.
Fixing CFTR.
-
Compounds have been found which move D F508
to the membrane.
-
These are called chemical chaperones.
-
None of these are close to trials yet.
-
Other compounds increase the activity of certain CFTR mutants.
-
Some of these are already approved for human use.
-
Trails of two of these, genistein and CPX, are moving forward.
Alternate anion channels.
-
Nature has done this experiment for us and it works.
-
But, if channels exist, they seem to work
-
If they do not exist, we are back to gene therapy.
-
‘Occult channels’ may still be a possibility.
"Conventional" treatments:
a new look.
-
All increases in CF longevity result from conventional therapies.
-
General strategy: reduce challenges, supply what is missing.
-
Pancreatic enzymes are again the paradigm.
Goal 1: minimize infection.
-
Avoidance is the first line of defense.
-
Continuous, prophylactic treatments make sense.
-
Treatments should be inhaled when possible.
-
Monitoring should be improved.
-
When infections are detected, eradication is the goal.
-
Multiple antibiotics are required.
Goal 2: minimize plugging.
-
Exercise?
-
Bronchodilators?
-
Physiotherapy?
Goal 3: minimize inflammation.
-
Religious pursuit of goals 1 & 2.
-
Ibuprofen
-
Inhaled antiproteases and antioxidants.
Roles of basic research in lung treatments
-
Better (different) inhaled antibiotics
-
Inhaled antifungicides.
-
Better (different) inhaled anti-inflammatory agents.
-
Inhaled antioxidants and antiproteases.
-
Improved delivery systems.
-
Improved monitoring of lung structure & function.
Beyond CF lung disease
-
Early treatment for liver disease
-
Early treatment for diabetes
Summary advice for treating CF
-
Earlier, earlier, earlier
-
More, more, more
-
Longer, longer, longer.